Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.

about

Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.

Item

http://www.wikidata.org/entity/Q47985089

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@en

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@nl

type

Item

label

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@en

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@nl

prefLabel

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@en

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@nl

P1476

Heparin versus bivalirudin for ...... analysis of the CPORT-E trial.

@en

P2093

Chao-Wei Hwang

http://www.w3.org/2001/XMLSchema#string

Cynthia C Lemmon

http://www.w3.org/2001/XMLSchema#string

Daniel Q Naiman

http://www.w3.org/2001/XMLSchema#string

Rani K Hasan

http://www.w3.org/2001/XMLSchema#string

Thomas Aversano

http://www.w3.org/2001/XMLSchema#string

Thomas Wang

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Bivalirudin during primary PCI in acute myocardial infarction

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI).

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium.

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes.

Bivalirudin started during emergency transport for primary PCI.

P304

366-377

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.26953

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J Czarny

P577

2017-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28160375

http://www.w3.org/2001/XMLSchema#string